Follow my blog with Bloglovin
Top headlines...
More news in the legal saga over the severity of Cymbalta's withdrawal symptoms: "Eli Lilly and Co. downplayed the withdrawal risk of its antidepressant drug Cymbalta to the point of fraud, a pair of women told a Virginia federal jury Monday, saying
Playing the chronic illness blame game
When we're chronically ill, it's easy to play the blame game. Every new symptom becomes part of the complicated mishmash of our illness. If our shoulder hurts, we think it must be a weird new fibro or ME/CFS pain. If we feel dizzy, we chalk it up to excessive brain fog. If we're super tired, we
This week’s fibromyalgia and ME/CFS news (week of August 17, 2015)
Top stories ...
Cymbalta drugmaker Eli Lilly & Co. has won round two against hundreds of patients who claim they weren't properly warned of the antidepressant's withdrawal symptoms. Cymbalta is one of three U.S. FDA-approved drugs commonly prescribed to treat fibromyalgia. A California judge
This week’s headlines (week of August 10, 2015)
Top stories ...
Eli Lilly & Co. has won round one of a legal battle against patients who allege the company hasn't been forthcoming about withdrawal symptoms from Cymbalta, an antidepressant commonly prescribed to treat fibromyalgia.
Good news for those with ME/CFS: Hemispherx Biopharma and
Using d-ribose for fibromyalgia and chronic fatigue syndrome
This post contains affiliate links.
I was scrolling through my Facebook feed a few days ago, and I noticed a post from a woman on one of the fibromyalgia/ME/CFS support groups, asking fellow members if they'd ever used prescription stimulants to relieve fatigue. Over the past couple of years,
This week’s headlines (week of August 3, 2015)
Top stories ...
More than $5 million in funding for ME/CFS research has been cut from the (U.S.) Centers for Disease Control and Prevention's 2016 budget. This is a BIG, BIG deal for the ME/CFS community because research dollars are already scant (see Cort Johnson's stories below). The Solve ME/CFS
This week’s headlines (week of July 27, 2015)
Top stories...
Is Lyrica 2.0 coming soon to a pharmacy near you? Japanese pharmaceutical company launches new 1,000-patient study in the U.S. and Canada to test the effectiveness of mirogabalin, a drug that works similar to Lyrica. Early reports indicate mirogabalin could be "more potent, have
This week’s headlines (week of July 20, 2015)
Top stories...
Has your physician ever refused to run a particular diagnostic test that you wanted? Soon, you won't need your physician's lab order any longer! A new service coming to more than 8,000 Walgreens drugstore locations in the U.S. will allow you to run your own blood tests at an
Topricin My Pain Away Fibro Cream review
Note: I was not compensated in any way for this Topricin My Pain Away Fibro Cream review. I purchased the product with my own money, and all opinions are my own.
Anyone who's had fibro for a while knows there are lots of lotions and potions that claim to heal our aches and pains. I'm not
This week’s headlines (week of July 13, 2015)
Top stories...
If you take NSAIDS (Advil/ibuprofen, Aleve/naproxen, Celebrex, etc.) for pain management, then you should probably read the latest warning from the the U.S. Food and Drug Administration.
This story and video from Palo Alto Online has received quite a few shares on social media
This week’s headlines (week of July 6, 2015)
This week's top stories...
Cancer and arthritis drug Rituximab shows great promise for some ME/CFS patients.
Pain News Network columnist Ellen Lenox Smith tackles the topic, "How to use medical marijuana without smoking." This is a very helpful article for anyone considering the use of medical
This week’s headlines (week of June 29, 2015)
This week's top stories...
The drug makers of fibro drugs Lyrica and Cymbalta are currently facing lawsuits that could cost them billions of dollars. In the UK, Pfizer is being accused of keeping physicians from prescribing a cheaper, generic version of Lyrica. In the U.S., some patients are suing